Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The peripheral blood of
systemic lupus erythematosus
patients showed an increased expression of CXCR5 positive T cells. However, the molecular mechanism of the abnormal expression of CXCR5 in
SLE
CD4
+
T cells remains unclear. The present study demonstrated that the levels of H3K4me3 and H3K36me3 in CXCR5 promoter were significantly higher in
SLE
patients than those in healthy controls. Furthermore, the expression of
SETD3
was upregulated in
SLE
CD4
+
T cells as compared to the healthy controls. Excessive
SETD3
increased the level of H3K4me3 and H3K36me3 and promoted the expression of CXCR5. These data strongly suggested that
SETD3
plays a major role in the regulation of CXCR5 expression and the progression of
SLE
.
...
PMID:Overexpression of CXCR5 in CD4
+
T cells of SLE patients caused by excessive SETD3. 3224 Aug 18